C‐Reactive Protein, Left Atrial Volume, and Atrial Fibrillation: A Prospective Study in High‐Risk Elderly

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Echocardiography

• Publication date

  2010-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1540-8175.2009.01039.xPMID 20070356
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation.

  2008cited by this paper
• Interleukin-6 and atrial fibrillation in patients with coronary artery disease: data from the Heart and Soul Study.

  2008cited by this paper
• Usefulness of left atrial volume index to predict heart failure hospitalization and mortality in ambulatory patients with coronary heart disease and comparison to left ventricular ejection fraction (from the Heart and Soul Study).

  2008cited by this paper
• The influence of exercise training on inflammatory cytokines and C-reactive protein.

  2007cited by this paper
• Comparison of C-reactive protein levels in patients who do and do not develop atrial fibrillation during electrophysiologic study.

  2007cited by this paper
• Effects of valsartan alone versus valsartan/simvastatin combination on ambulatory blood pressure, C-reactive protein, lipoproteins, and monocyte chemoattractant protein-1 in patients with hyperlipidemia and hypertension.

  2007cited by this paper
• Physical Activity and Reduced Risk of Cardiovascular Events: Potential Mediating Mechanisms

  2007cited by this paper
• Multiple biomarkers for the prediction of first major cardiovascular events and death.

  2006cited by this paper
• Two-dimensional echocardiographic methods for assessment of left atrial volume.

  2006cited by this paper
• C-Reactive protein in lone atrial fibrillation.

  2006cited by this paper
• Prediction of cardiovascular outcomes with left atrial size: is volume superior to area or diameter?

  2006cited by this paper
• C-Reactive Protein and the 10-Year Incidence of Coronary Heart Disease in Older Men and Women: The Cardiovascular Health Study

  2005cited by this paper
• Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardio

  2005cited by this paper
• Relation of elevated C-reactive protein and interleukin-6 levels to left atrial size and duration of episodes in patients with atrial fibrillation.

  2005cited by this paper
• Irbesartan and Lipoic Acid Improve Endothelial Function and Reduce Markers of Inflammation in the Metabolic Syndrome: Results of the Irbesartan and Lipoic Acid in Endothelial Dysfunction (ISLAND) Study

  2005cited by this paper
• Epidemiological profile of atrial fibrillation: a contemporary perspective.

  2005cited by this paper
• C-Reactive Protein in Heart Failure: Prognostic Value and the Effect of Valsartan

  2005cited by this paper
• C-Reactive protein elevation predicts the occurrence of atrial structural remodeling in patients with paroxysmal atrial fibrillation

  2005cited by this paper
• Inflammatory markers and the risk of coronary heart disease in men and women.

  2004cited by this paper
• CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the clinical practice discussion group.

  2004cited by this paper
• Left atrial volume and the risk of paroxysmal atrial fibrillation in patients with hypertrophic cardiomyopathy.

  2004cited by this paper
• CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice Report From the Laboratory Science Discussion Group

  2004cited by this paper
• Determinants of atrial fibrillation development in patients with hypertrophic cardiomyopathy.

  2004cited by this paper
• Differences in Tachyarrhythmia Detection and Implantable Cardioverter Defibrillator Therapy by Primary or Secondary Prevention Indication in Cardiac Resynchronization Therapy Patients

  2004cited by this paper
• Risks for atrial fibrillation and congestive heart failure in patients >/=65 years of age with abnormal left ventricular diastolic relaxation.

  2004cited by this paper
• Effect of six months' exercise training on C-reactive protein levels in healthy elderly subjects.

  2004cited by this paper
• Inflammation as a Risk Factor for Atrial Fibrillation

  2003cited by this paper
• Prediction of risk for first age-related cardiovascular events in an elderly population: the incremental value of echocardiography.

  2003cited by this paper
• C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events: An 8-Year Follow-Up of 14 719 Initially Healthy American Women

  2003cited by this paper
• Physical Activity and Hemostatic and Inflammatory Variables in Elderly Men

  2002cited by this paper
• Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events.

  2002cited by this paper
• Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events*

  2002cited by this paper
• Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden.

  2002cited by this paper
• Left atrial volume: important risk marker of incident atrial fibrillation in 1655 older men and women.

  2001cited by this paper
• C-Reactive Protein Elevation in Patients With Atrial Arrhythmias: Inflammatory Mechanisms and Persistence of Atrial Fibrillation

  2001cited by this paper
• The New England Journal

  2000cited by this paper
• C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.

  2000cited by this paper
• Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive Protein

  1999cited by this paper
• Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators.

  1999cited by this paper
• Acute-phase proteins and other systemic responses to inflammation.

  1999cited by this paper
• Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators.

  1998cited by this paper
• C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction.

  1998cited by this paper
• Prospective study of herpes simplex virus, cytomegalovirus, and the risk of future myocardial infarction and stroke.

  1998cited by this paper
• Histological substrate of atrial biopsies in patients with lone atrial fibrillation.

  1997cited by this paper
• Impact of Left Ventricular Structure on the Incidence of Hypertension: The Framingham Heart Study

  1994cited by this paper
• The natural history of congestive heart failure: the Framingham study.

  1971cited by this paper
• American Society of Echocardiography

  year unknowncited by this paper

• Biomarkers of Atrial Fibrillation-Related Pathways and Left Atrial Structure and Function in an Overweight and Obese Population

  2025cites this paper
• The cardioprotective effects of HTK solution and conventional blood cardioplegia in patients with atrial fibrillation undergoing valvular replacement and Cox maze III procedure

  2025cites this paper
• Markers associated with atrial fibrillation in hypertensive patients

  2024cites this paper
• Biomarkers of atrial fibrillation-related pathways and left atrial structure and function in an overweight and obese population

  2024cites this paper
• Blood pressure, hypertension and the risk of atrial fibrillation: a systematic review and meta-analysis of cohort studies

  2023cites this paper
• C-reactive protein and atrial fibrillation: Insights from epidemiological and Mendelian randomization studies.

  2022cites this paper
• Serum High-Sensitivity C-Reactive Protein Levels and the Development of Atrial Fibrillation in a General Japanese Population　- The Hisayama Study.

  2021cites this paper
• Cox-maze III procedure for atrial fibrillation during valve surgery: a single institution experience

  2020cites this paper
• CHA2DS2-VASc score and left atrial volume dilatation synergistically predict incident atrial fibrillation in hypertension: an observational study from the Campania Salute Network registry

  2019cites this paper
• Risk Factors of Recurrence of Atrial Fibrillation (AF) After AF Surgery in Patients With AF and Mitral Valve Disease.

  2018cites this paper
• Diabetes mellitus, blood glucose and the risk of atrial fibrillation: A systematic review and meta-analysis of cohort studies.

  2018cites this paper
• Assessment of left atrial mechanical function and synchrony in paroxysmal atrial fibrillation with two‐dimensional speckle tracking echocardiography

  2017cites this paper
• Body mass index, abdominal fatness, fat mass and the risk of atrial fibrillation: a systematic review and dose–response meta-analysis of prospective studies

  2017cites this paper
• Usefulness of CHADS2 and CHA2DS2-VASc Scores in the Prediction of New-Onset Atrial Fibrillation: A Population-Based Study.

  2016cites this paper
• The relationship between left atrial remodelling, atrial fibrillation burden and thrombogenesis

  2016cites this paper
• NT-proBNP is a powerful predictor for incident atrial fibrillation - Validation of a multimarker approach.

  2016cites this paper
• Risk factors responsible for atrial fibrillation development between symptomatic patients with concealed or manifest atrioventricular accessory pathways☆

  2015cites this paper
• The Early Stage of the Atrial Electroanatomic Remodeling as Substrates for Atrial Fibrillation in Hypertensive Patients

  2014cites this paper
• What is the atrium trying to tell us?

  2013cites this paper
• New Risk Markers in Atrial Fibrillation

  2013cites this paper
• Biomarkers in atrial fibrillation: a clinical review.

  2013influential citation
• Identification of clinical risk factors of atrial fibrillation in congestive heart failure.

  2013cites this paper
• Systolic left ventricular function according to left ventricular concentricity and dilatation in hypertensive patients: the Losartan Intervention For Endpoint reduction in hypertension study

  2013cites this paper
• Inflammatory activation in an unselected population of subjects with atrial fibrillation: links with structural heart disease, atrial remodeling and recent onset

  2013cites this paper
• Association of inflammatory factors with occurrence and recurrence of atrial fibrillation: a meta-analysis.

  2013cites this paper
• The CHADS2 score predicts ischemic stroke in the absence of atrial fibrillation among subjects with coronary heart disease: data from the Heart and Soul Study.

  2011cites this paper
• The CHADS 2 Score Predicts Ischemic Stroke in the Absence of Atrial Fibrillation Among Patients with Coronary Heart Disease : Data from the Heart and Soul Study

  2011cites this paper
• Assessment of left atrial volume: a focus on echocardiographic methods and clinical implications

  2011influential citation
• Atrial Electrical and Structural Changes Associated with Longstanding Hypertension in Humans: Implications for the Substrate for Atrial Fibrillation

  2011cites this paper
• Left Atrial Dysfunction Is a Predictor of Postcoronary Artery Bypass Atrial Fibrillation: Association of Left Atrial Strain and Strain Rate Assessed by Speckle Tracking

  2011cites this paper
• Computer-Based Automated Left Atrium Segmentation and Volumetry from ECG-Gated Coronary CT Angiography Data: Comparison with Manual Slice Segmentation and Ultrasound Planimetric Methods

  2010cites this paper